Objective: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD).
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schizophrenia in adults.
Acid reflux ... in your stomach backs up into the esophagus, tube that carries food from your mouth to your stomach. Another term for acid reflux is “gastroesophageal reflux disease ...